Reimbursement as a driver for commercial and clinical strategies

At the end attendees will understand the process to maximize the efficiency (or return on investment) of commercial and clinical strategies towards reimbursement. This means developing a process that will generate measurable positive results for a medical company that intends to sell its products into the market.

Introduction

This is a full day course in which attendees will focus on three key learning points:
 
1) What is the concept behind Reimbursement, considering real examples from countries in Europe?
2) Who are the key market decision-makers, and what are their needs?
3) How does Reimbursement drive commercial and clinical strategies?

Reimbursement is the primary driver of sales for medical companies. However, these same companies typically perceive reimbursement as a long-term, expensive and uncertain process in terms of results. This is the opposite of the immediate focus on sales results; so how to integrate these two aspects of short and long-term focus?

The strategy for reimbursement starts by demonstrating the value of a medical product, which means quantifying its clinical and economic benefits. This immediately integrates clinical and commercial teams in speaking the same language and aligning evidence and product features to maximize reimbursement approvals. Market decision-makers are not only interested in efficacy, which typically comes from large randomized controlled trials. They must also see the effectiveness (or real-life results) of products and their economic benefits which can be perfectly demonstrated with smaller studies.
 
At the end, this course is intended to clarify the aspects of reimbursement, shifting it from a technical and isolated corner to the center of an integrated commercial and clinical strategy.
 
Who should attend?

This course is targeted towards professionals involved in:

• Strategic planning
• Health Economics
• Reimbursement
• Clinical
• Marketing
• Sales
 
This is not a technical course and previous knowledge of reimbursement is not necessary.

The learning benefits will be enhanced from the diverse perspective of attendees, who will all be focusing on the process of demonstrating the value of a medical product and contributing with their own experiences.

Course benefit

At the end attendees will understand the process to maximize the efficiency (or return on investment) of commercial and clinical strategies towards reimbursement. This means developing a process that will generate measurable positive results for a medical company that intends to sell its products into the market.
 
Course language

The course will be conducted in English.
 
Course form

The course is a combination of a series of facilitation sessions, which are the core of the learning topics, and lectures about specific topics to be incorporated into the group discussions. This is a highly practical course with focus on “learning by doing”. Active participation is required to be eligible for course certificate.
 
Instructor

Ernesto M. Nogueira, Senior Principal Advisor, Qmed Consulting

 

"A very competent teacher, a very nice background diversity, good discussions, nice level of information"

Participant, Fall 2014

 

Kontakt

Morten Petersen
Kursuskoordinator
49184703